CID 202830

9,10-dihydro-11-(2-morpholinoethoxy)methyl-9,10-ethanoanthracene hydrochloride

Structural Information

Molecular Formula
C23H27NO2
SMILES
C1COCCN1CCOCC2CC3C4=CC=CC=C4C2C5=CC=CC=C35
InChI
InChI=1S/C23H27NO2/c1-3-7-20-18(5-1)22-15-17(23(20)21-8-4-2-6-19(21)22)16-26-14-11-24-9-12-25-13-10-24/h1-8,17,22-23H,9-16H2
InChIKey
ZFTRSBZKXJTMQP-UHFFFAOYSA-N
Compound name
4-[2-(15-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenylmethoxy)ethyl]morpholine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

349.2042 Da
Monoisotopic Mass

3.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 350.21148 181.2
[M+Na]+ 372.19342 195.7
[M+NH4]+ 367.23802 192.5
[M+K]+ 388.16736 185.4
[M-H]- 348.19692 186.9
[M+Na-2H]- 370.17887 183.6
[M]+ 349.20365 185.2
[M]- 349.20475 185.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.